FY2016 Financial Highlights

29 %

growth in revenues
during FY2016

₹6,610 Crores

READ MORE

111 %

growth in operating profit
during FY2016

₹1,872 Crores

READ MORE

126 %

growth in net profit1 during FY2016

₹951 Crores

READ MORE

Note: 1. FY2015 net profit excludes exceptional gain on sale of 11% stake in Vodafone India partly offset by the amount written down on account of scaling back of our investments in NCE research.

Chairman’s Message

Dear Shareholders,

The Piramal Group has re-invented itself multiple times in the last three decades. In 1988, we entered pharmaceuticals space and in over a period of two decades, we became one of the top pharma companies in India.

Read More
Our
Businesses

In the healthcare space, PEL has a strong presence in Pharma Solutions, Critical Care and Consumer

Pharma Solutions
(PPS)

FY2016 REVENUEs

₹2,290 Cr

18%

5- year Revenue CAGR

Among the top integrated global Contract Development and Manufacturing Organisations (CDMOs) offering both APIs and Formulations

Read more

Critical Care
(PCC)

FY2016 REVENUEs

₹876 Cr

18%

5- year Revenue CAGR

Among top three players in Inhalation Anaesthesia segment globally

Read more

Consume
Products (OTC)

FY2016 REVENUEs

₹393 Cr

18%

7- year Revenue CAGR

Strong brand portfolio - include key brands such as Saridon, i-pill and Lacto Calamine

Read more

PEL’s Financial Services segment offers a complete suite of financial products to meet the diverse needs of its customers.

Wholesale
Lending

Loan Book

₹13,048 Cr

25%+ RoE

Lending to real estate developers and under special situation opportunities (in various sectors including renewables,

Read more

Alternative Asset
Management

AUM

₹8,717 Cr

Currently manages 7 funds, 3 third party mandates and 2 managed accounts

Read more

Investment in Shriram Group

Amount invested

₹4,583 Cr

20% stake in Shriram Capital (SCL). Invested ₹2,146 Crores.

Read more

PEL’s Information Management business is a global, market leading, decision support platform in the healthcare information services sector.

Decision Resources Group

FY2016 Revenues

₹1,156 Cr

13.4% Y-o-Y Growth

Portfolio is structured into three product categories - Data and Analytics, Research Products and Consulting Services

Read more